Men are also vulnerable to thinning bones as they age.
The American Academy of Orthopaedic Surgeons says risk factors for osteoporosis in men include:

Drinking excessive amounts of alcohol or using tobacco.
Not exercising regularly.
Having a low body-mass index.
Getting insufficient vitamin D and calcium.
Taking certain medications, including anticonvulsants, oral glucocorticoids or heparin.
Getting older.
Having a family history of fractures […]

continue reading from " Osteoporosis can affect men, too "

A study at Hassenpflug University of the Schleswig-Holstein Medical Center in Germany, has found that men take longer than women to recover from knee replacement surgery, but after a year, they catch up and there are no differences in surgery outcomes at that time.
When the authors took age, BMI (body mass index) and co-morbidities into […]

continue reading from " Men take longer than women to recover from knee replacement surgery, "

When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.
Ths is the conclusion of a new study at UCLA’s Jonsson Comprehensive Cancer Center. Researchers found that when a common type of prostate cancer was treated with conventional […]

continue reading from " Men who die of prostate cancer are those that become resistant to therapy "

A recent study at the University of Michigan has found a new drug, known as Cabozantinib, designed to target mainly two important pathways linked to the growth and spread of prostate cancer is showing promise to kill tumors that have spread to the bone.
After treatment, men in trial with metastatic prostate cancer reported some tumor regressions in areas of […]

continue reading from " New drug shows promise in stopping prostate cancer spread to bone "

According to study results were presented at the 2011 annual meeting of the American Urological Association (AUA), among men with prostate cancer that has stopped responding to hormonal therapy, the bone drug Xgeva (denosumab) delayed the spread of cancer to the bones.
Xgeva is a bone drug that targets a protein known as the RANK ligand. […]

continue reading from " Xgeva delays bone metastases in prostate cancer patients "

A new stusy at University of Michigan study has concluded that prostate and breast cancer usually recur in the bone.
Acording to researchers prostate cancer cells specifically target and eventually overrun the bone marrow niche, a specialized area for hematopoietic stem cells, which make red and white blood cells.
Once in the niche, the cancer cells stay dormant and […]

continue reading from " Prostate cancer usually recur in bone "

Researchers at the University of Melbourne in Australia say a new virtual bone biopsy may be a key tool to identify future bone problems for men with prostate cancer.
Prostate cancer is the second most common cancer in men worldwide. The most commonly known treatment for this disease is androgen deprivation therapy or ADT. ADT suppresses […]

continue reading from " Bone biopsies identify men at risk for fractures "

According to a new research conducted at the University of Sydney, Australia, osteoporosis, a diseases common in women that makes bones brittle and easily breakable with age, also affects men.
The study suggests that this debilitating condition is often overlooked in elderly Australian men. This means that they cannot be treated early and have to suffer […]

continue reading from " Osteoporosis common but underestimated in old men "

A new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health, suggests men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease
The finding, published […]

continue reading from " Aggressive prostate cancer patients tend to retain denser bones "

Researchers have long known that prostate cancers that spread, or metastasize, often migrate to bone. That idea led a team at the Department of Urology at the Johns Hopkins University School of Medicine, to investigate whether there is a connection between bone characteristics and prostate cancer development and metastasis.
This new research suggests men who develop […]

continue reading from " Study reveals apparent link between prostate cancer and bone density "